U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IMMUNOGLOBULIN G1 (148-ASPARTIC ACID,171-CYSTEINE,174-CYSTEINE,221-GLYCINE,256-LYSINE,400-ARGININE,410-GLUTAMIC ACID), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL PSB105 .GAMMA.1-CHAIN), (174->194''),(201->162'')-(BIS)DISUL
Preferred Name English
TUVONRALIMAB
INN  
Official Name English
tuvonralimab [INN]
Common Name English
Code System Code Type Description
FDA UNII
8XWO7LI4LO
Created by admin on Wed Apr 02 00:19:26 GMT 2025 , Edited by admin on Wed Apr 02 00:19:26 GMT 2025
PRIMARY
NCI_THESAURUS
C191954
Created by admin on Wed Apr 02 00:19:26 GMT 2025 , Edited by admin on Wed Apr 02 00:19:26 GMT 2025
PRIMARY
CAS
2417649-44-4
Created by admin on Wed Apr 02 00:19:26 GMT 2025 , Edited by admin on Wed Apr 02 00:19:26 GMT 2025
PRIMARY
SMS_ID
300000041915
Created by admin on Wed Apr 02 00:19:26 GMT 2025 , Edited by admin on Wed Apr 02 00:19:26 GMT 2025
PRIMARY
INN
11841
Created by admin on Wed Apr 02 00:19:26 GMT 2025 , Edited by admin on Wed Apr 02 00:19:26 GMT 2025
PRIMARY
ACTIVE MOIETY
TUVONRALIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966